A distinct profile of tryptophan metabolism along the kynurenine pathway downstream of toll-like receptor activation in irritable bowel syndrome

Frontiers in Pharmacology

Volumn 3 MAY, Issue , 2012, Pages

  Clarke, Gerard ^a,b   McKernan, Declan P ^c   Gaszner, Gabor ^b   Quigley, Eamonn M ^a,b   Cryan, John F ^a,b   Dinan, Timothy G ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Cytokine; Ido; Irritable bowel syndrome; Kynurenine pathway; Toll like receptors; Tryptophan

Indexed keywords

KYNURENINE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR AGONIST; TRYPTOPHAN;

ADULT; AGED; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; AMINO ACID SYNTHESIS; ARTICLE; BLOOD CULTURE; BRAIN; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTESTINE; IRRITABLE COLON; MALE; SIGNAL TRANSDUCTION; TRYPTOPHAN METABOLISM;

EID: 84866038338     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00090     Document Type: Article

References (58)

1. Akira, S., and Takeda, K. (2004). Toll-like receptor signalling. NatRev Immunol. 4, 499-511.
2. Bercik, P., Collins, S. M., and Verdu, E. F. (2012). Microbes and the gutbrain axis. Neurogastroenterol. Motil. 24, 405-413.
3. Brint, E. K., Macsharry, J., Fanning, A., Shanahan, F., and Quigley, E. M. (2011). Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am. J. Gastroenterol. 106, 329-336.
4. Clarke, G., Fitzgerald, P., Cryan, J. F., Cassidy, E. M., Quigley, E. M., and Dinan, T. G. (2009a). Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3dioxygenase activation in a male cohort. BMC Gastroenterol. 9, 6. doi:10.1186/1471-230X-9-6
5. Clarke, G., Fitzgerald, P., Hennessy, A. A., Cassidy, E. M., Quigley, E. M., Ross, P., Stanton, C., Cryan, J. F., and Dinan, T. G. (2010). Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome. J. Lipid Res. 51, 1186-1192.
6. Clarke, G., Quigley, E. M., Cryan, J. F., and Dinan, T. G. (2009b). Irritable bowel syndrome: towards biomarker identification. Trends. Mol. Med. 15, 478-489.
7. Connor, T. J., Starr, N., O'Sullivan, J. B., and Harkin, A. (2008). Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFNgamma? Neurosci. Lett. 441, 29-34.
8. Cremon, C., Gargano, L., MorselliLabate, A. M., Santini, D., Cogliandro, R. F., De Giorgio, R., Stanghellini, V., Corinaldesi, R., and Barbara, G. (2009). Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am. J. Gastroenterol. 104, 392-400.
9. Crowell, M. D. (2004). Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br. J. Pharmacol. 141, 1285-1293.
10. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., and Kelley, K. W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46-56.
11. Dinan, T. G., Clarke, G., Quigley, E. M., Scott, L. V., Shanahan, F., Cryan, J., Cooney, J., and Keeling, P. W. (2008). Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am.J.Gastroenterol. 103, 2570-2576.
12. Dinan, T. G., Quigley, E. M., Ahmed, S. M., Scully, P., O'Bbrien, S., O'Mahony, L., O'Mahony, S., Shanahan, F., and Keeling, P. W. (2006). Hypothalamicpituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130, 304-311.
13. Drossman, D. A., and Dumitrascu, D. L. (2006). Rome III: new standard for functional gastrointestinal disorders. J. Gastrointestin. Liver Dis. 15, 237-241.
14. Ehlers, M., and Ravetch, J. V. (2007). Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance. Trends Immunol. 28, 74-79.
15. Fitzgerald, P., Cassidy Eugene, M., Clarke, G., Scully, P., Barry, S., Quigley Eamonn, M. M., Shanahan, F., Cryan, J., and Dinan Timothy, G. (2008). Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. Neurogastroenterol. Motil. 20, 1291-1297.
16. Forsythe, P., Sudo, N., Dinan, T., Taylor,V. H., and Bienenstock, J. (2010). Mood and gut feelings. Brain Behav. Immun. 24, 9-16.
17. Francis, C. Y., Morris, J., and Whorwell, P. J. (1997). The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment. Pharmacol. Ther. 11, 395-402.
18. Gomez-Llorente, C., Munoz, S., and Gil, A. (2010). Role of toll-like receptors in the development of immunotolerance mediated by probiotics. Proc. Nutr. Soc. 69, 381-389.
19. Grenham, S., Clarke, G., Cryan, J. F., and Dinan, T. G. (2011). Brain-gutmicrobe communication in health and disease. Front. Physiol. 2:94. doi:10.3389/fphys.2011.00094
20. Gupta, N. K., Thaker, A. I., Kanuri, N., Riehl, T. E., Rowley, C. W., Stenson, W. F., and Ciorba, M. A. (2011). Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity. Inflamm. Bowel Dis. doi:10.1002/ibd.21849
21. Hajjar, A. M., O'Mahony, D. S., Ozinsky, A., Underhill, D. M., Aderem, A., Klebanoff, S. J., and Wilson, C. B. (2001). Cutting edge: functional interactions between tolllike receptor (TLR) 2 and TLR1 or TLR6 in response to phenolsoluble modulin. J. Immunol. 166, 15-19.
22. Herve, C., Beyne, P., Jamault, H., and Delacoux, E. (1996). Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J. Chromatogr. B Biomed. Appl. 675, 157-161.
23. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres,S.,and Hartmann,G. (2002). Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531-4537.
24. Horton,D. L.,and Remick,D. G. (2010). Delayed addition of glucocorticoids selectively suppresses cytokine production in stimulated human whole blood. Clin. Vaccine Immunol. 17, 979-985.
25. Kariko, K., Ni, H., Capodici, J., Lamphier, M., and Weissman, D. (2004). mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279, 12542-12550.
26. Kennedy, P. J., Clarke, G., Quigley, E. M., Groeger, J. A., Dinan, T. G., and Cryan, J. F. (2012). Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci. Biobehav. Rev. 36, 310-340.
27. Liebregts, T., Adam, B., Bredack, C., Roth, A., Heinzel, S., Lester, S., Downie-Doyle, S., Smith, E., Drew, P., Talley, N. J., and Holtmann, G. (2007). Immune activation in patients with irritable bowel syndrome. Gastroenterology 132, 913-920.
28. Lisak, R. P., Nedelkoska, L., Studzinski, D., Bealmear, B., Xu, W., and Benjamins, J. A. (2011). Cytokines regulate neuronal gene expression: differential effects of Th1, Th2 and monocyte/macrophage cytokines. J. Neuroimmunol. 238, 19-33.
29. Mahanonda, R., Sa-Ard-Iam, N., Montreekachon, P., Pimkhaokham, A., Yongvanichit, K., Fukuda, M. M., and Pichyangkul, S. (2007). IL-8 and IDO expression by human gingival fibroblasts via TLRs. J. Immunol. 178, 1151-1157.
30. Makela, S. M., Osterlund, P., and Julkunen, I. (2011). TLR ligands induce synergistic interferon-beta and interferon-lambda1 gene expression in human monocytederived dendritic cells. Mol. Immunol. 48, 505-515.
31. Marshak-Rothstein, A. (2006). Tolllike receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6, 823-835.
32. Marshall, J. D., Heeke, D. S., Gesner, M. L., Livingston, B., and Van Nest, G. (2007). Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand. J. Leukoc. Biol. 82, 497-508.
33. Mayer, E. A. (2011). Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 12, 453-466.
34. McKernan, D. P., Gaszner, G., Quigley, E. M., Cryan, J. F., and Dinan, T. G. (2011). Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment. Pharmacol. Ther. 33, 1045-1052.
35. McKernan, D. P., Nolan, A., Brint, E. K., O'Mahony, S. M., Hyland, N. P., Cryan, J. F., and Dinan, T. G. (2009). Toll-like receptor mRNA expression is selectively increased in the colonic mucosa of two animal models relevant to irritable bowel syndrome. PLoS ONE 4, e8226. doi:10.1371/journal.pone.0008226
36. Molina, M. A., Gamboa, E. M., Tello, P. C., Benavides, P. Z., Leon, L. C., Guerra, R. T., and Padilla, C. R. (2006). Spontaneous inflammatory cytokine gene expression in normal human peripheral blood mononuclear cells. Lymphat. Res. Biol. 4, 34-40.
37. Muller, N., and Schwarz, M. J. (2007). The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol. Psychiatry 12, 988-1000.
38. O'Malley, D., Quigley, E. M., Dinan, T. G., and Cryan, J. F. (2011). Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome? Brain Behav. Immun. 25, 1333-1341.
39. Ohman, L., Isaksson, S., Lindmark, A. C., Posserud, I., Stotzer, P. O., Strid, H., Sjovall, H., and Simren, M. (2009a). T-cell activation in patients with irritable bowel syndrome. Am. J. Gastroenterol. 104, 1205-1212.
40. Ohman, L., Lindmark, A. C., Isaksson, S., Posserud, I., Strid, H., Sjovall, H., and Simren, M. (2009b). B-cell activation in patients with irritable bowel syndrome (IBS). Neurogastroenterol. Motil. 21, 644-650.
41. Ohman, L., Lindmark, A. C., Isaksson, S., Posserud, I., Strid, H., Sjovall, H., and Simren, M. (2012). Increased TLR2 expression on blood monocytes in irritable bowel syndrome patients. Eur. J. Gastroenterol. Hepatol. 24, 398-405.
42. Ohman, L., and Simren, M. (2007). New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig. Liver Dis. 39, 201-215.
43. Ohman, L., and Simren, M. (2010). Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat. Rev. Gastroenterol. Hepatol. 7, 163-173.
44. Pace, T. W., and Heim, C. M. (2011). A short review on the psychoneuroimmunology of posttraumatic stress disorder:from risk factors to medical comorbidities. Brain Behav. Immun. 25, 6-13.
45. Quigley, E. M. (2006). Changing face of irritable bowel syndrome. World J. Gastroenterol. 12, 1-5.
46. Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., and Miller, A. H. (2009). CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol. Psychiatry 15, 393-403.
47. Reinhart, P. H., and Kelly, J. W. (2011). Treating the periphery to ameliorate neurodegenerative diseases. Cell 145, 813-814.
48. Ruddick, J. P., Evans, A. K., Nutt, D. J., Lightman, S. L., Rook, G. A., and Lowry, C. A. (2006). Tryptophan metabolism in the central nervous system: medical implications. Expert Rev. Mol. Med. 8, 1-27.
49. Schroecksnadel,K.,Winkler,C.,Wirleitner, B., Schennach, H., and Fuchs, D. (2005). Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro. Clin. Exp. Immunol. 140, 41-45.
50. Schroecksnadel, S., Sucher, R., Kurz, K., Fuchs, D., and Brandacher, G. (2011). Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells. Transpl. Immunol. 25, 119-123.
51. Schwarcz, R., and Pellicciari, R. (2002). Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J. Pharmacol. Exp. Ther. 303, 1-10.
52. Scully, P., McKernan, D. P., Keohane, J., Groeger, D., Shanahan, F., Dinan, T. G., and Quigley, E. M. (2010). Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal comorbidity. Am. J. Gastroenterol. 105, 2235-2243.
53. Sioud, M. (2006). Innate sensing of self and non-self RNAs by tolllike receptors. Trends. Mol. Med. 12, 167-176.
54. Spitzer, R. L., Kroenke, K., and Williams, J. B. (1999). Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282, 1737-1744.
55. Takeuchi, O., and Akira, S. (2010). Pattern recognition receptors and inflammation. Cell 140, 805-820.
56. Taylor, M. W., and Feng, G. S. (1991). Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB. 5, 2516-2522.
57. Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., and Yang, H. (2006). HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26, 174-179.
58. Zwilling, D., Huang, S. Y., Sathyasaikumar, K. V., Notarangelo, F. M., Guidetti, P., Wu, H. Q., Lee, J., Truong, J., Andrews-Zwilling, Y., Hsieh, E. W., Louie, J. Y., Wu, T., Scearce-Levie, K., Patrick, C., Adame, A., Giorgini, F., Moussaoui, S., Laue, G., Rassoulpour, A., Flik, G., Huang, Y., Muchowski, J. M., Masliah, E., Schwarcz, R., and Muchowski, P. J. (2011). Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell 145, 863-874.